RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Shanghai Medicilon - Stock

Shanghai Medicilon P/E 2024

Shanghai Medicilon P/E

17.01

Ticker

688202.SS

ISIN

CNE100003NQ8

As of Jun 27, 2024, Shanghai Medicilon's P/E ratio was 17.01, a -104.57% change from the -372.34 P/E ratio recorded in the previous year.

The Shanghai Medicilon P/E history

Shanghai Medicilon Aktienanalyse

What does Shanghai Medicilon do?

Shanghai Medicilon ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Shanghai Medicilon's P/E Ratio

The Price to Earnings (P/E) Ratio of Shanghai Medicilon is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Shanghai Medicilon's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Shanghai Medicilon is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Shanghai Medicilon’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Shanghai Medicilon Stock

What is the price-to-earnings ratio of Shanghai Medicilon?

The price-earnings ratio of Shanghai Medicilon is currently 17.01.

How has the price-earnings ratio of Shanghai Medicilon changed compared to last year?

The price-to-earnings ratio of Shanghai Medicilon has increased by -104.57% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Shanghai Medicilon high compared to other companies?

Yes, the price-to-earnings ratio of Shanghai Medicilon is high compared to other companies.

How does an increase in the price-earnings ratio of Shanghai Medicilon affect the company?

An increase in the price-earnings ratio of Shanghai Medicilon would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Shanghai Medicilon affect the company?

A decrease in the price-earnings ratio of Shanghai Medicilon would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Shanghai Medicilon?

Some factors that influence the price-earnings ratio of Shanghai Medicilon are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Shanghai Medicilon pay?

Over the past 12 months, Shanghai Medicilon paid a dividend of 0.28 CNY . This corresponds to a dividend yield of about 1.01 %. For the coming 12 months, Shanghai Medicilon is expected to pay a dividend of 0.32 CNY.

What is the dividend yield of Shanghai Medicilon?

The current dividend yield of Shanghai Medicilon is 1.01 %.

When does Shanghai Medicilon pay dividends?

Shanghai Medicilon pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Shanghai Medicilon?

Shanghai Medicilon paid dividends every year for the past 5 years.

What is the dividend of Shanghai Medicilon?

For the upcoming 12 months, dividends amounting to 0.32 CNY are expected. This corresponds to a dividend yield of 1.18 %.

In which sector is Shanghai Medicilon located?

Shanghai Medicilon is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shanghai Medicilon kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shanghai Medicilon from 6/2/2023 amounting to 0.279 CNY, you needed to have the stock in your portfolio before the ex-date on 6/2/2023.

When did Shanghai Medicilon pay the last dividend?

The last dividend was paid out on 6/2/2023.

What was the dividend of Shanghai Medicilon in the year 2023?

In the year 2023, Shanghai Medicilon distributed 0.699 CNY as dividends.

In which currency does Shanghai Medicilon pay out the dividend?

The dividends of Shanghai Medicilon are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shanghai Medicilon

Our stock analysis for Shanghai Medicilon Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shanghai Medicilon Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.